The Atlantic Coast Retina Club (ACRC) Meeting and Macula 2023 returned to Boston last week for three days of events at Mass Eye and Ear and the Seaport Hotel. More than 300 people attended from...
Wentworth-Douglass Hospital teamed up with retina specialists at Mass Eye and Ear to launch a new Retinopathy of Prematurity (ROP) program that allows infants to remain local while receiving...
This year’s Iraty Award for Research in Retinal Diseases honors Leo A. Kim, MD, PhD, an Associate Professor of Ophthalmology at Harvard Medical School (HMS) and the Monte J. Wallace Ophthalmology...
Three talented vitreoretinal surgery fellows at Mass Eye and Ear were recognized with the following awards and fellowships. The 2022 retina awards and fellowships will be announced in October.
Cris Jacoba, MD, and Konstantina Sampani, MD, both fellows at the Beetham Eye Institute at Joslin Diabetes Center, placed first and second, respectively, in the New England Ophthalmological Society...
Ivana K. Kim, MD, Associate Professor of Ophthalmology at Harvard Medical School and Director of the Macular Degeneration Unit and Co-Director of the Ocular Melanoma Center, was selected to present...
Leo A. Kim, MD, PhD,a clinician scientist with surgical expertise and an innovator in the treatment of retinal diseases associated with neovascularization and fibrosis and an Associate Professor of...
This year's Iraty Award for Research in Retinal Diseases honors Petr Baranov, PhD, a scientist at Schepens Eye Research Institute of Mass. Eye and Ear and Assistant Professor of Ophthalmology...
A recent meta-analysis, led by Deeba Husain, MD, suggests that AMD patients present distinct plasma metabolomic profiles, which vary with disease severity. After analyzing blood samples of their 491...
OCU400, a novel gene therapy platform developed by Neena Haider, PhD, Harvard Medical School Associate Professor of Ophthalmology and Associate Scientist at the Schepens Eye Research Institute of Mass...
A study led by Eleftherios Paschalis, PhD, describes a mechanism by which patients with acute ocular injuries become susceptible to progressive neurodegeneration long after the injury has taken...
Boston, Mass. — Massachusetts Eye and Ear made medical history on Tuesday by performing the first post-FDA approval gene therapy for patients with a form of inherited blindness. The occasion marks...
The VitreoRetinal Surgery Foundation recognized four trainees with research awards and fellowships, enabling them to pursue research investigations at Mass. Eye and Ear and Schepens Eye Research...
Ocugen, Inc. has obtained an exclusive worldwide license to develop and commercialize future ophthalmology products based on groundbreaking technology developed by Neena Haider, PhD, Associate...
Santiago Delgado-Tirado, MD, MSc, a research fellow under the mentorship ofJoseph Arboleda-Velasquez, MD, PhD, and Leo Kim, MD, PhD, received the Alfonso Martin Escudero Foundation Fellowship. This...
James “Tony” Stefater, MD, PhD, a vitreoretinal fellow at Mass. Eye and Ear, received the 2017 Vitreoretinal Research Scholarship from the Robert Machemer Foundation in the amount of $20,000 over...
Patrick Oellers, MD, is the inaugural recipient of the Thomas J. Madden Fellowship in Retina at Mass. Eye and Ear. Patrick is completing his first year as a Retina Surgery Fellow. The fellowship was...
Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease.
Boston, Mass. — It’s the part of the eye exam everyone hates: the pupil-dilating eye drops. The drops work by opening the pupil and preventing the iris from constricting in response to light...